Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Itraconazole in Castrate-resistant Prostate Cancer Post-chemotherapy

NCT01450683 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01450683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01450683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Itraconazole in Castrate-resistant Prostate Cancer Post-chemotherapy
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2010
Completion date
April 30, 2011
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgen-insensitive prostate cancer, castrate-resistant prostate cancer (crpc), hormone-refractory prostate cancer, metastatic disease, prostate cancer, prostatic neoplasms